Understanding GLP-1 Medications
GLP-1 receptor agonists represent a breakthrough in weight management and metabolic health. These medications mimic natural hormones that regulate appetite and blood sugar levels.
Learn how cutting-edge medications are transforming health journeys
Learn MoreGLP-1 receptor agonists represent a breakthrough in weight management and metabolic health. These medications mimic natural hormones that regulate appetite and blood sugar levels.
Ozempic is a once-weekly injectable medication that mimics the GLP-1 hormone, helping to regulate blood sugar and reduce appetite.
Approved for Type 2 Diabetes management and weight loss in adults with obesity or overweight with weight-related conditions.
Victoza is a daily injectable GLP-1 receptor agonist that helps control blood sugar levels and reduces appetite through its effect on the brain's hunger centers.
Long-standing approval for Type 2 Diabetes treatment, with additional indication for weight management in specific patient populations.
Mounjaro is a once-weekly injectable medication that mimics two gut hormones, GLP-1 and GIP, to regulate blood sugar and appetite.
Approved for Type 2 diabetes management with demonstrated significant weight loss benefits.
Wegovy is a GLP-1 receptor agonist specifically approved for chronic weight management in adults and adolescents.
Specifically approved for chronic weight management in adults with obesity or overweight with related conditions.
Trulicity is a once-weekly GLP-1 receptor agonist that improves blood sugar control and supports weight management.
Approved for Type 2 diabetes management and reducing cardiovascular risk in adults with established cardiovascular disease.
Saxenda is a daily injectable GLP-1 receptor agonist specifically formulated for weight management.
Approved for chronic weight management in adults and adolescents aged 12-17 with obesity or overweight with weight-related conditions.
Slide to see how different medications affect your health over time
The FDA has recently approved Mounjaro (tirzepatide) for chronic weight management, marking a significant advancement in obesity treatment options.
Read MoreRecent studies demonstrate sustained weight loss benefits and improved cardiovascular outcomes with GLP-1 medications over extended periods.
View StudiesMedical associations have updated their guidelines to include GLP-1 medications as a primary treatment option for obesity management.
Learn More
"Lost 50 pounds in 6 months with the help of GLP-1 medication and lifestyle changes."
"Finally found a sustainable way to manage my weight with GLP-1 treatment."
"The combination of GLP-1 and healthy habits changed my life completely."